When I've spoken to Russell he has always stressed that avoiding dilution is a primary focus so I'm confident he'll continue to negotiate good outcomes.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025